Ozmosi | AZD-2961 Drug Profile
Contact Us
Drug Profile
Using advanced filters...
Advanced Search [+]

AZD-2961

Alternative Names: AZD-2961, AZD 2961, AZD2961
Clinical Status: Active
Latest Update: 2024-04-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Company: AstraZeneca
Company Location: Europe
Company Founding Year: 1999
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AZD-2961

Countries in Clinic: Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Peru, Philippines, Poland, South Africa, South Korea, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States, Vietnam

Active Clinical Trial Count: 2

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Heart Failure|Kidney Diseases

Phase 2: Albuminuria

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

jRCT2031240054

 jRCT2031240054

P2

Not yet recruiting

Albuminuria

2026-03-31

jRCT2031240037

 jRCT2031240037

P3

Recruiting

Heart Failure|Kidney Diseases

2027-09-30

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions